Focusing on CAFs, our analysis revealed a novel subpopulation marked by CD34+PI16+, which gave rise to the classical ACTA2+MCAM+ CAFs in tumor, also known as myCAF (data unpublished). This evidence concerns the gene PI16 and neoplasm.